Wednesday, May 28, 2014

Worthington & Caron Proud to Again Sponsor the 4th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

On June 7 some of the leading physicians involved in the diagnosis and treatment of pleural mesothelioma will meet at the Sheraton Delfina in Santa Monica, California for the 4th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. The symposium will be an all-day affair and begin at 8 am.

Worthington & Caron is proud to sponsor this symposium for the fourth consecutive year.

Once again, Dr. Robert B. Cameron will lead the symposium.  In addition to being the Director of the UCLA Mesothelioma Comprehensive Research Program, Dr. Cameron also is the Chief of Thoracic Surgery at the West Los Angeles VA Medical Center and Scientific Advisor at the Pacific Meso Center.

Although the seminar is geared toward physicians, it also offers continuing medical education credit and the latest information on mesothelioma for medical students, nurses, mesothelioma patients and their families

The Symposium is co-hosted by UCLA and the Pacific Meso Center. Joining Dr. Cameron will be several physicians (both 'home-grown' and international colleagues) and mesothelioma advocates, including:

  • Olga Olevsky, MD, of UCLA Medical Center
  • Percy Lee, MD, Chief Thoracic Radiation Oncology at UCLA
  • Dr. Richard Lemen, Former Assistant Surgeon General of the United States
  • Irene I-Lan Wu, MD, UCLA Pain Management Center 
  • Joachim Aerts, MD, of Erasmus MC Cancer Institute in the Netherlands
  • Jan P. van Meerbeeck, MD of Antwerp University Hospital in Belgium,
  • Linda Reinstein, President/CEO and Co-Founder Asbestos Disease Awareness Organization,
The symposium will be divided into four sessions: Lung-Sparing Surgical Techniques, Lung-Sparing Adjuvant Therapies, Potential Future Adjuvant Therapies and Supportive Therapies.

To register for the symposium, click here.


For a copy of the brochure, click here.

No comments:

Post a Comment